Cellromax Science financial statements
셀로맥스사이언스KRX:471820 · KOSDAQ₩4,080-1.09%
2026-10-07 closeCellromax Science's 2025 annual results accompany close-price data dated 2026-10-07. 2025 revenue was KRW 22.18B. 2025 operating profit was KRW 2.84B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy